Comments
Loading...

Ocuphire Pharma

OCUPNASDAQ
Logo brought to you by Benzinga Data
$1.33
0.021.53%
At Close: -
$1.35
0.021.50%
After Hours: 4:44 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$26.00
Lowest Price Target1
$17.00
Consensus Price Target1
$19.80

Ocuphire Pharma (NASDAQ:OCUP) Stock, Analyst Ratings, Price Targets, Forecasts

Ocuphire Pharma Inc has a consensus price target of $19.8 based on the ratings of 5 analysts. The high is $26 issued by HC Wainwright & Co. on November 24, 2021. The low is $17 issued by Cantor Fitzgerald on August 14, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Canaccord Genuity, and HC Wainwright & Co. on August 15, 2024, August 14, 2024, and May 13, 2024, respectively. With an average price target of $18.67 between HC Wainwright & Co., Canaccord Genuity, and HC Wainwright & Co., there's an implied 1282.72% upside for Ocuphire Pharma Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Canaccord Genuity
Alliance Global Partners
Cantor Fitzgerald
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Ocuphire Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Ocuphire Pharma (OCUP) stock?

A

The latest price target for Ocuphire Pharma (NASDAQ:OCUP) was reported by HC Wainwright & Co. on August 15, 2024. The analyst firm set a price target for $18.00 expecting OCUP to rise to within 12 months (a possible 1233.33% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ocuphire Pharma (OCUP)?

A

The latest analyst rating for Ocuphire Pharma (NASDAQ:OCUP) was provided by HC Wainwright & Co., and Ocuphire Pharma maintained their buy rating.

Q

When was the last upgrade for Ocuphire Pharma (OCUP)?

A

There is no last upgrade for Ocuphire Pharma

Q

When was the last downgrade for Ocuphire Pharma (OCUP)?

A

There is no last downgrade for Ocuphire Pharma.

Q

When is the next analyst rating going to be posted or updated for Ocuphire Pharma (OCUP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocuphire Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocuphire Pharma was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.

Q

Is the Analyst Rating Ocuphire Pharma (OCUP) correct?

A

While ratings are subjective and will change, the latest Ocuphire Pharma (OCUP) rating was a maintained with a price target of $20.00 to $18.00. The current price Ocuphire Pharma (OCUP) is trading at is $1.35, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch